Author： Maas A.I.
Publisher： Informa Healthcare
ISSN： 1354-3784
Source： Expert Opinion on Investigational Drugs, Vol.10, Iss.4, 2001-04, pp. : 753-767
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Cannabinoids as Neuroprotective Agents in Traumatic Brain Injury
Current Pharmaceutical Design, Vol. 10, Iss. 18, 2004-07 ,pp. :
Access to resources
Recommend
Adenosine Neuromodulation and Traumatic Brain Injury
Current Neuropharmacology, Vol. 7, Iss. 3, 2009-09 ,pp. :
Biomarkers in Silent Traumatic Brain Injury
Current Pharmaceutical Design, Vol. 22, Iss. 6, 2016-02 ,pp. :
Oxidative Stress in Traumatic Brain Injury
Current Medicinal Chemistry, Vol. 21, Iss. 10, 2014-04 ,pp. :
Bridge Between Neuroimmunity and Traumatic Brain Injury
Current Pharmaceutical Design, Vol. 20, Iss. 26, 2014-08 ,pp. :